quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:05·578d
SECFiling
Alimera Sciences Inc. logo

SEC Form EFFECT filed by Alimera Sciences Inc.

ALIM· Alimera Sciences Inc.
Health Care
Original source

Companies

  • ALIM
    Alimera Sciences Inc.
    Health Care

Recent analyst ratings

  • Jun 25UpdateH.C. Wainwright-
  • Mar 25UpdateMaxim Group$10.00
  • Oct 30UpdateAlliance Global Partners$8.00
  • Feb 25UpdateHC Wainwright & Co.$10.00
  • Aug 16UpdateHC Wainwright & Co.$12.00

Related

  • SEC574d
    SEC Form 15-12G filed by Alimera Sciences Inc.
  • SEC578d
    SEC Form EFFECT filed by Alimera Sciences Inc.
  • INSIDER582d
    SEC Form 4 filed by Chief Financial Officer Maltz Elliot
  • INSIDER582d
    SEC Form 4 filed by Director Kaseta Michael
  • INSIDER582d
    Chief Marketing Officer & SVP Holland David returned 187,756 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER582d
    Director Snisarenko John returned 10,000 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER582d
    President and CEO Eiswirth Richard S Jr returned 324,018 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER582d
    SEC Form 4 filed by Director Pax Margaret
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022